Y Intercept (Hong Kong) LTD Gilead Sciences, Inc. Transaction History

Y Intercept (Hong Kong) LTD

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$71.58 - $87.29 $1.42 Million - $1.73 Million	19,824 Added 300.14%	26,429 $1.94 Million
Q4 2023 Feb 13, 2024	BUY	$73.27 - $83.09 $483,948 - $548,809	6,605 New	6,605 $535,000
Q2 2023 Aug 14, 2023	BUY	$76.01 - $86.7 $842,874 - $961,416	11,089 New	11,089 $854,000
Q4 2022 Feb 14, 2023	SELL	$62.32 - $89.47 $1.58 Million - $2.27 Million	-25,320 Closed	0 $0
Q3 2022 Feb 14, 2023	BUY	$59.54 - $68.01 $1.51 Million - $1.72 Million	25,320 New	25,320 $1.56 Million
Q1 2022 May 16, 2022	SELL	$57.92 - $72.58 $945,486 - $1.18 Million	-16,324 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $1.06 Million - $1.2 Million	16,324 New	16,324 $1.19 Million
Q3 2021 Nov 15, 2021	SELL	$67.69 - $73.03 $1.76 Million - $1.9 Million	-25,993 Closed	0 $0
Q2 2021 Aug 26, 2021	BUY	$63.47 - $69.35 $1.65 Million - $1.8 Million	25,993 New	25,993 $1.79 Million
Q2 2021 Aug 12, 2021	SELL	$63.47 - $69.35 $749,707 - $819,162	-11,812 Closed	0 $1.79 Million
Q1 2021 May 12, 2021	BUY	$60.0 - $68.46 $708,720 - $808,649	11,812 New	11,812 $774,000

1,942

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $117B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Y Intercept (Hong Kong) LTD, based on Form 13F filings with the SEC.

Stay updated on Y Intercept (Hong Kong) LTD with notifications on news.